Converging Pathways: Atopic Dermatitis and Alopecia Areata

At AAD 2025 | March 6, 2025 | Time: 2:00 - 6:00 PM Eastern Local Time

Orange County Convention Center, 9800 International Dr, Orlando, FL 32819 USA | Room W202ABC 

REGISTER NOW

PROGRAM CHAIRS

Emma Guttman, MD PhD | IEC Founder & Director Icahn School of Medicine at Mount Sinai New York, NY		Natasha Mesinkovska, MD PhD University of California Irvine School of Medicine Irvine, CA

LEARNING OBJECTIVES

This educational session aims to explore the shared immunological and genetic mechanisms that underlie these two autoimmune conditions. The session will delve into these converging pathways so that dermatologists and allergists alike gain insights into novel therapeutic strategies that target shared molecular mechanisms, offering potential for more personalized treatment approaches for patients with comorbid AD and AA.

At the conclusion of this symposium, participants will be able to:
1. Analyze and compare the pathogenic mechanisms of Alopecia Areata (AA) and Atopic Dermatitis (AD), identifying both shared and distinct immunological pathways to improve diagnostic and treatment strategies for patients with either or both conditions.
2. Evaluate the epidemiological data linking Alopecia Areata to atopic comorbidities, with an emphasis on identifying key patient populations at increased risk for developing AD alongside AA.
3. Assess emerging treatment developments for both Atopic Dermatitis and Alopecia Areata, with a focus on understanding how new therapies for AD may influence the management of AA in both adult and pediatric populations.

AGENDA

2 – 2:05 PM Welcome from the IEC
Alan Irvine, MD DSc | IEC President | Trinity College Dublin, Children’s Health | Dublin, Ireland

2:05 – 2:10 PM Program Overview from Symposium Co-Chairs
Emma Guttman, MD PhD | IEC Director | Icahn School of Medicine at Mount Sinai | New York, NY
and
Natasha Mesinkovska, MD PhD | University of California Irvine School of Medicine | Irvine, CA

2:10 - 2:30 PM Pathogenic similarities and differences between Alopecia areata and Atopic dermatitis
Emma Guttman, MD PhD | IEC Director | Icahn School of Medicine at Mount Sinai | New York, NY

2:30 -2:50 PM The epidemiology of alopecia areata and atopic comorbidities
Benjamin Ungar, MD | IEC Councilor | Icahn School of Medicine at Mount Sinai New York, NY

2:50 – 3:10 PM New treatment developments in atopic dermatitis and how these relate to alopecia areata
Peter A. Lio, MD | IEC Councilor | Integrative Eczema Center Chicago, IL

3:10 – 3:30 PM New treatments for adults with alopecia areata
Natasha Mesinkovska, MD PhD | University of California Irvine School of Medicine | Irvine, CA

3:30 – 3:50 PM New developments for children with alopecia areata with and without atopy
Yael Renert-Yuval, MD | IEC Councilor | Schneider Children's Medical Center of Israel | Tel Aviv, Israel; Icahn School of Medicine at Mount Sinai | New York, NY

3:50 – 4:10 PM Break

4:10 – 4:20 PM Research Update from the NEA
Wendy Smith Begolka, MBS | National Eczema Council | Novato, CA

4:20 - 4:30 PM Research Update from the NAAF
George C. Gondo, MA | National Alopecia Areata Foundation | Knoxville, TN

4:30 – 5:45 PM Patient Discussion Panel
Moderated by Jessica Johnson, MPH | National Eczema Council and George C. Gondo, MA | National Alopecia Areata Foundation

5:45 - 6 PM Q&A, Closing Remarks, & Adjourn
Emma Guttman and Natasha Mesinkovska

This educational symposium presented by the IEC is offered at no cost to attendees.

HEALTH AND SAFETY TRAVEL RESOURCES

IEC will comply with AAD and local mandates at the time of the in-person meeting.